HalioDx to expand North American operations, establish facility in VA Bio+Tech Park
RICHMOND—Governor Ralph Northam today announced that HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, has invested more than $1 million to establish a CLIA laboratory in the VA Bio+Tech Park in the City of Richmond. Virginia was selected over North Carolina for the project, which will create over 20 new jobs.